Results 151 to 154 of about 58,255 (154)

Knowledge and beliefs of endocrine disruptors in pediatrics: all hands on deck! [PDF]

Front Public Health
Portefaix A, Loppinet T, Tourvieilhe L, Balice G, de Veron de La Combe N, Kassai B, Bacchetta J.   +6 more
europepmc   +1 more source

Arteriovenous Access Creation and eGFR Decline in Patients with CKD.

J Am Soc Nephrol
Tabcheh AH, Coscas R, Lambert O, Stengel B, Frimat L, Massy Z, Combe C, Guedes M, Pecoits-Filho R, Boucquemont J, Alencar De Pinho N, CKD-REIN Study Collaborators.   +11 more
europepmc   +1 more source

The Cardiovascular Safety of Tumour Necrosis Factor Inhibitors in Arthritic Conditions: A Structured Review with Recommendations. [PDF]

Rheumatol Ther
Avouac J, Ait-Oufella H, Habauzit C, Benkhalifa S, Combe B.   +4 more
europepmc   +1 more source

Authors' Reply: The Potential Outcome-Modification Influences Introduced by ESKD Life Plan on eGFR Slopes.

J Am Soc Nephrol
Tabcheh AH, Boucquemont J, Pecoits-Filho R, Alencar De Pinho N, CKD-REIN Study Collaborators.   +4 more
europepmc   +1 more source